Cite
Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
MLA
Wang, Yong, et al. “Efficacy and Safety of Bivalirudin during Percutaneous Coronary Intervention in High-Bleeding-Risk Elderly Patients with Chronic Total Occlusion: A Prospective Randomized Controlled Trial.” Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions, vol. 93, no. S1, Feb. 2019, pp. 825–31. EBSCOhost, https://doi.org/10.1002/ccd.28087.
APA
Wang, Y., Zhao, H.-W., Wang, C.-F., Fan, C.-Y., Zhang, X.-J., Zhu, Y., Luo, D.-F., Yu, G.-N., Hou, A.-J., & Luan, B. (2019). Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial. Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions, 93(S1), 825–831. https://doi.org/10.1002/ccd.28087
Chicago
Wang, Yong, Hong-Wei Zhao, Cheng-Fu Wang, Chun-Yu Fan, Xiao-Jiao Zhang, Yu Zhu, De-Feng Luo, Guo-Ning Yu, Ai-Jie Hou, and Bo Luan. 2019. “Efficacy and Safety of Bivalirudin during Percutaneous Coronary Intervention in High-Bleeding-Risk Elderly Patients with Chronic Total Occlusion: A Prospective Randomized Controlled Trial.” Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions 93 (S1): 825–31. doi:10.1002/ccd.28087.